MAGE-1 gene encodes a human melanoma antigen, recognized by syngeneic
cytotoxic T lymphocytes (CTL). MAGE-1 transcripts are also detectable
in breast cancers, in non-small-cell lung carcinomas and in central ne
rvous system tumors. In order to identify, in cellular preparations, t
he protein encompassing the antigenic peptide, we generated a panel of
monoclonal antibodies (MAbs) against the MAGE-1 gene product by using
, as immunogen, a full-length recombinant preparation (rMAGE-1), obtai
ned through expression cloning of the relevant gene in E. coli. Four r
eagents were obtained recognizing both rMAGE-1 and the 46-kDa native p
rotein in cell lines expressing MAGE-1 mRNA. No positivity could be de
tected in MAGE-1-mRNA-negative melanoma lines. No surface labelling of
MAGE-1-positive cell lines could be observed. In contrast, on permeab
ilization of MZ2 melanoma cells, all 4 MAbs induced efficient staining
, as detected by cytofluorography. Fluorescence microscopy shows that
MAGE-1 gene product is a cytoplasmic protein clustered in paranuclear
organelle-like structures. Thus, MAGE-1 protein location closely resem
bles that of P91A and P198 murine-tumor antigens. (C) 1994 Wiley-Liss,
Inc.